Table 1 Clinical characteristics of the patient.

From: Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study

 

Patient

Reference range

Age (years)

71 y

–

HBsAg

(+) >250 IU/ml

(−) <0.05 IU/ml

HBsAb

(−) 0.21 mIU/ml

(−) <10.0 mIU/ml

HBeAg

(−) 0.24 S/CO

(−) <1 S/CO

HBeAb

(+) 0.01 S/CO

(−) >1 S/CO

HBcAb

(+) 11.62 S/CO

(−) <1 S/CO

HBV DNA

<103 copies/ml

<103 copies/ml

HCV Ab

(−) 0.07 S/CO

(−) <1 S/CO

AFP

3.6 ng/ml

0.00–13.20 ng/ml

CEA

2.11 ng/ml

0.00–5.50 ng/ml

  1. HBsAg, Hepatitis B surface antigen; HBsAb, Antibody to hepatitis B surface antigen; HBeAg, Hepatitis B e antigen; HBeAb, Antibody to hepatitis B e antigen; HBcAb, Hepatitis B core antibody; HCV, Hepatitis C virus; AFP, Alpha-fetoprotein; CEA, Carcinoembryonic antigen; and S/CO, Sample/cut off.
Back to article page